T1	p 70 159	postoperative rectal cancer patients treated with adjuvant concurrent chemoradiotherapy ]
T2	p 345 367	rectal cancer patients
T3	p 372 431	received capecitabine-based postoperative chemoradiotherapy
T4	p 438 439	)
T5	p 450 613	Four hundred patients with stage II and III rectal cancer received postoperative CRT of capecitabine with or without oxaliplatin were accumulated and prostectively
T6	p 630 637	study .
T7	p 642 650	patients
T8	p 691 728	Two hundred and twenty-eight patients
T9	p 1373 1408	136 patients presented severe AEs .
T10	p 2558 2580	rectal cancer patients
T11	i 18 42	CCND1 A870G polymorphism
T12	i 120 161	adjuvant concurrent chemoradiotherapy ] .
T13	i 241 279	single nucleotide polymorphism ( SNP )
T14	i 313 327	events ( AEs )
T15	i 381 439	capecitabine-based postoperative chemoradiotherapy ( CRT )
T16	i 531 613	CRT of capecitabine with or without oxaliplatin were accumulated and prostectively
T17	i 747 799	concurrent capecitabine and radiotherapy ( Cap-CRT )
T18	i 832 901	with capecitabine and oxaliplatin plus radiotherapy ( Cap-Oxa-CRT ) .
T19	i 922 928	graded
T20	i 946 964	Common Terminology
T21	i 995 1009	v. 3.0 ( CTCAE
T22	i 1079 1162	polymerase chain reaction-based restriction fragment length polymorphism ( PCR-RFLP
T23	i 1205 1208	SNP
T24	i 2085 2087	GG
T25	i 2091 2093	GA
T26	i 2306 2308	GG
T27	i 2312 2314	GA
T28	i 2440 2452	polymorphism
T29	i 2594 2665	adjuvant concurrent chemoradiotherapy of capecitabine and oxaliplatin .
T30	o 46 66	acute adverse events
T31	o 902 916	Adverse events
T32	o 953 973	Terminology Criteria
T33	o 978 992	Adverse Events
T34	o 1090 1175	chain reaction-based restriction fragment length polymorphism ( PCR-RFLP ) analysis .
T35	o 1213 1222	acute AEs
T36	o 1246 1252	ratios
T37	o 1255 1258	ORs
T38	o 1396 1406	severe AEs
T39	o 1449 1461	genotypes GG
T40	o 1464 1473	GA and AA
T41	o 1606 1614	Diarrhea
T42	o 1640 1659	and severe diarrhea
T43	o 1691 1705	frequencies of
T44	o 1710 1740	three genotypes GG , GA and AA
T45	o 1884 1892	diarrhea
T46	o 1966 1990	risk for severe diarrhea
T47	o 2220 2244	risk for severe diarrhea
T48	o 2398 2415	severe diarrhea .